The efficacy of orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC) associated with hepatitis C virus (HCV) is not well defined. This study examines the variables that may determine the outcome of OLT for HCC in HCV patients. From 1990 to 1999, 463 OLTs were performed for HCV c
Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma
✍ Scribed by Espen Melum; Styrbjörn Friman; Kristian Bjøro; Allan Rasmussen; Helena Isoniemi; Henrik Gjertsen; Lars Bäckman; Antti Oksanen; Michael Olausson; Frans F. Duraj; Bo-Göran Ericzon
- Book ID
- 116651412
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 131 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The incidence of hepatocellular carcinoma (HCC) is on the rise worldwide as the most common primary hepatic malignancy. In the US approximately one half of all HCC is related to Hepatitis C virus (HCV) infection. The relationship between the primary disease and HCC recurrence after liver transplanta
End-stage liver disease secondary to hepatitis C virus (HCV) infection is the leading indication for liver transplantation in the United States. Recurrence of HCV infection is nearly universal. We studied the patients enrolled in the National Institute of Diabetes and Digestive and Kidney Diseases L